Plasma levels of SP-A and SP-B are increased in patients with ARDS [70] and in at-risk patients [119, 120], whereas lower SP-A and SP-B levels were found in the BAL fluid of patients at risk for ARDS prior to the onset of the clinical syndrome. This evidence concerns the gene FASLG and acute respiratory distress syndrome.